US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

35.24

+0.61001.76%

Post-market: 35.240.00000.00%16:10 EST

Volume:470.51K

Turnover:16.51M

Market Cap:4.00B

PE:-18.06

High:35.55

Open:35.26

Low:34.47

Close:34.63

52wk High:42.00

52wk Low:14.06

Shares:113.39M

Float Shares:64.72M

Volume Ratio:0.79

T/O Rate:0.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9515

EPS(LYR):-2.5604

ROE:-39.94%

ROA:-20.70%

PB:5.49

PE(LYR):-13.76

Loading ...

Overview Company News Filings

NewAmsterdam Pharma gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans

NewAmsterdam Pharma Executives to Join Guggenheim Emerging Outlook Biotech Summit

NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares

NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares

RBC Raises Price Target on NewAmsterdam Pharma to $47 From $44, Keeps Outperform, Speculative Risk

MT Newswires Live

NewAmsterdam Pharma Company Nv : RBC Raises Target Price to $47 From $44

THOMSON REUTERS

Should NewAmsterdam’s Multi-Indication Obicetrapib Strategy Reshape How NAMS Investors View Pipeline Concentration?

Simply Wall St.

NewAmsterdam Pharma highlights 2025 achievements, 2026 priorities

NewAmsterdam Pharma Enrolls First Patients in RUBENS Phase 3 Trial for Obicetrapib Combo in Metabolic Syndrome

NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies

Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

NewAmsterdam Pharma Company Nv : Leerink Partners Raises Target Price to $55 From $45

THOMSON REUTERS

Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

NewAmsterdam Pharma Grants Stock Options to New Hire Under 2024 Inducement Plan

Chief Accounting Officer Louise Kooij Sells Common Shares of NewAmsterdam Pharma Company NV

We're Hopeful That NewAmsterdam Pharma (NASDAQ:NAMS) Will Use Its Cash Wisely

Simply Wall St.

NewAmsterdam Pharma Company Nv : Stifel Raises Target Price to $50 From $44

THOMSON REUTERS

National Presto, Garrett Motion, and More Stocks See Action From Activist Investors -- Barrons.com

NewAmsterdam Pharma Grants Stock Options to New Hires Under 2024 Inducement Plan

NewAmsterdam Pharma Executives to Join Major Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":35.24,"timestamp":1771362000000,"preClose":34.63,"halted":0,"volume":470506,"hourTrading":{"tag":"盘后","latestPrice":35.24,"preClose":35.24,"latestTime":"16:10 EST","volume":6668,"amount":234980.32,"timestamp":1771362604723,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.017614784868611014,"floatShares":64720411,"shares":113390804,"eps":-1.951455,"marketStatus":"Post-Mkt","change":0.61,"latestTime":"02-17 16:37:31 EST","open":35.26,"high":35.55,"low":34.47,"amount":16514243.23553,"amplitude":0.031187,"askPrice":38.72,"askSize":100,"bidPrice":31.85,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.951455,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771376400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":34.63,"preHourTrading":{"tag":"盘前","latestPrice":35.06,"preClose":34.63,"latestTime":"09:29 EST","volume":833,"amount":28965.13431,"timestamp":1771338562162,"change":0.43,"changeRate":0.012417,"amplitude":0.09361},"postHourTrading":{"tag":"盘后","latestPrice":35.24,"preClose":35.24,"latestTime":"16:10 EST","volume":6668,"amount":234980.32,"timestamp":1771362604723,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.791794,"impliedVol":0.7744,"impliedVolPercentile":0.6215},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":64720411,"roa":"-20.70%","roe":"-39.94%","lyrEps":-2.560438,"volumeRatio":0.791794,"shares":113390804,"dividePrice":0,"high":35.55,"amplitude":0.031187,"preClose":34.63,"low":34.47,"week52Low":14.06,"pbRate":"5.49","psRate":"113.38","week52High":42,"institutionHeld":0,"latestPrice":35.24,"eps":-1.951455,"divideRate":0,"volume":470506,"delay":0,"ttmEps":-1.951455,"open":35.26,"prevYearClose":35.08,"prevWeekClose":34.63,"prevMonthClose":31.12,"prevQuarterClose":35.08,"fiveDayClose":35,"twentyDayClose":31.65,"sixtyDayClose":38.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-05","symbol":"NAMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-08-06","symbol":"NAMS","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4667,"buy":0.4667,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":15,"updateTime":1761109200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2026-02-13","current":-18.058321,"percent":0.355808,"low":-27.491906,"twenty":-21.024533,"median":-11.596174,"eighty":-4.995999,"high":37.547018,"avg":-10.815471,"sd":12.248357,"marketCap":3952803427},"quantilePoints":[{"date":"2021-02-19","current":-21.896664,"twenty":-21.861751,"median":-21.619037,"eighty":-21.46054,"marketCap":152734680},{"date":"2021-02-26","current":-21.012022,"twenty":-21.861751,"median":-21.551533,"eighty":-21.347758,"marketCap":146156220},{"date":"2021-03-05","current":-21.131171,"twenty":-21.83275,"median":-21.378316,"eighty":-21.121888,"marketCap":144726120},{"date":"2021-03-12","current":-21.057477,"twenty":-21.702996,"median":-21.336928,"eighty":-21.039295,"marketCap":144583110},{"date":"2021-03-19","current":-20.921405,"twenty":-21.589261,"median":-21.248455,"eighty":-20.956826,"marketCap":143153010},{"date":"2021-03-26","current":-20.670206,"twenty":-21.547958,"median":-21.13039,"eighty":-20.79868,"marketCap":140149800},{"date":"2021-04-01","current":-20.845813,"twenty":-21.531241,"median":-21.121823,"eighty":-20.817601,"marketCap":141007860},{"date":"2021-04-09","current":-21.225903,"twenty":-21.467898,"median":-21.109261,"eighty":-20.79095,"marketCap":145012140},{"date":"2021-04-16","current":-20.537749,"twenty":-21.367336,"median":-21.07922,"eighty":-20.761675,"marketCap":141436890},{"date":"2021-04-23","current":-20.315019,"twenty":-21.347758,"median":-20.984107,"eighty":-20.655391,"marketCap":140864850},{"date":"2021-04-30","current":-20.575716,"twenty":-21.338162,"median":-20.952872,"eighty":-20.552936,"marketCap":142294950},{"date":"2021-05-07","current":-20.262992,"twenty":-21.300508,"median":-20.893278,"eighty":-20.441966,"marketCap":141579900},{"date":"2021-05-14","current":-20.126121,"twenty":-21.252461,"median":-20.822297,"eighty":-20.370365,"marketCap":140435820},{"date":"2021-05-21","current":-20.063477,"twenty":-21.239434,"median":-20.785932,"eighty":-20.317104,"marketCap":140578830},{"date":"2021-05-28","current":-9.074203,"twenty":-21.215604,"median":-20.72844,"eighty":-20.270407,"marketCap":63580250},{"date":"2021-06-04","current":-9.099058,"twenty":-21.186359,"median":-20.671226,"eighty":-20.246426,"marketCap":63645797},{"date":"2021-06-11","current":-20.256213,"twenty":-21.131171,"median":-20.62297,"eighty":-20.108533,"marketCap":140864850},{"date":"2021-06-18","current":-20.772768,"twenty":-21.130859,"median":-20.59844,"eighty":-20.118,"marketCap":141579900},{"date":"2021-06-25","current":-20.724223,"twenty":-21.128116,"median":-20.62297,"eighty":-20.123197,"marketCap":142294950},{"date":"2021-07-02","current":-20.626893,"twenty":-21.122017,"median":-20.616149,"eighty":-20.125343,"marketCap":140435820},{"date":"2021-07-09","current":-20.380574,"twenty":-21.1215,"median":-20.614557,"eighty":-20.126121,"marketCap":139005720},{"date":"2021-07-16","current":-20.519425,"twenty":-21.109261,"median":-20.575716,"eighty":-20.156594,"marketCap":139291740},{"date":"2021-07-23","current":-20.512371,"twenty":-21.100962,"median":-20.537878,"eighty":-20.242284,"marketCap":138719700},{"date":"2021-07-30","current":-20.299111,"twenty":-21.057477,"median":-20.519425,"eighty":-20.242284,"marketCap":138433680},{"date":"2021-08-06","current":-20.554664,"twenty":-21.012022,"median":-20.514719,"eighty":-20.242284,"marketCap":139005720},{"date":"2021-08-13","current":-20.447221,"twenty":-20.984107,"median":-20.517067,"eighty":-20.256213,"marketCap":138719700},{"date":"2021-08-20","current":-20.697321,"twenty":-20.975132,"median":-20.51883,"eighty":-20.262992,"marketCap":139005720},{"date":"2021-08-27","current":-20.379723,"twenty":-20.972644,"median":-20.518236,"eighty":-20.265529,"marketCap":138147660},{"date":"2021-09-03","current":-20.932843,"twenty":-20.9331,"median":-20.51883,"eighty":-20.267469,"marketCap":143010000},{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-05-02","current":-9.10459,"twenty":-21.123639,"median":-10.998302,"eighty":-4.034765,"marketCap":2199650774},{"date":"2025-05-09","current":-11.536892,"twenty":-21.121629,"median":-10.997201,"eighty":-4.055194,"marketCap":2161528945},{"date":"2025-05-16","current":-11.205615,"twenty":-21.120569,"median":-10.998302,"eighty":-4.084594,"marketCap":2099461659},{"date":"2025-05-23","current":-10.953938,"twenty":-21.111476,"median":-11.006409,"eighty":-4.290374,"marketCap":2052307975},{"date":"2025-05-30","current":-10.564438,"twenty":-21.108578,"median":-10.998097,"eighty":-4.342797,"marketCap":1979332035},{"date":"2025-06-06","current":-11.690992,"twenty":-21.105474,"median":-11.002458,"eighty":-4.35749,"marketCap":2190400908},{"date":"2025-06-13","current":-12.601823,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"marketCap":2361052337},{"date":"2025-06-20","current":-10.906,"twenty":-21.096009,"median":-11.034638,"eighty":-4.422768,"marketCap":2043326321},{"date":"2025-06-27","current":-11.055808,"twenty":-21.087156,"median":-11.017754,"eighty":-4.497549,"marketCap":2071393990},{"date":"2025-07-03","current":-11.894731,"twenty":-21.083291,"median":-11.017754,"eighty":-4.606816,"marketCap":2228572938},{"date":"2025-07-11","current":-13.195061,"twenty":-21.075684,"median":-11.055808,"eighty":-4.79464,"marketCap":2472200307},{"date":"2025-07-18","current":-13.171092,"twenty":-21.071944,"median":-11.081388,"eighty":-4.810613,"marketCap":2467709480},{"date":"2025-07-25","current":-14.016008,"twenty":-21.067824,"median":-11.091761,"eighty":-4.839398,"marketCap":2626011135},{"date":"2025-08-01","current":-13.069223,"twenty":-21.06562,"median":-11.111477,"eighty":-4.845791,"marketCap":2448623465},{"date":"2025-08-08","current":-15.555229,"twenty":-21.05775,"median":-11.119592,"eighty":-4.850879,"marketCap":2577734743},{"date":"2025-08-15","current":-17.10683,"twenty":-21.05745,"median":-11.126176,"eighty":-4.861355,"marketCap":2834858287},{"date":"2025-08-22","current":-16.610684,"twenty":-21.057344,"median":-11.154761,"eighty":-4.872322,"marketCap":2752639513},{"date":"2025-08-29","current":-16.277655,"twenty":-21.055392,"median":-11.163241,"eighty":-4.875603,"marketCap":2697451569},{"date":"2025-09-05","current":-17.439859,"twenty":-21.047582,"median":-11.170454,"eighty":-4.879205,"marketCap":2890046232},{"date":"2025-09-12","current":-18.078731,"twenty":-21.03344,"median":-11.181125,"eighty":-4.882597,"marketCap":2995916982},{"date":"2025-09-19","current":-18.167086,"twenty":-21.02751,"median":-11.201038,"eighty":-4.893553,"marketCap":3010558682},{"date":"2025-09-26","current":-17.868039,"twenty":-21.012624,"median":-11.225569,"eighty":-4.916273,"marketCap":2961002160},{"date":"2025-10-03","current":-20.865303,"twenty":-21.012022,"median":-11.235632,"eighty":-4.940196,"marketCap":3457693660},{"date":"2025-10-10","current":-22.4319,"twenty":-21.03344,"median":-11.250767,"eighty":-4.945659,"marketCap":3717302256},{"date":"2025-10-17","current":-24.786892,"twenty":-21.057477,"median":-11.275775,"eighty":-4.95567,"marketCap":4107559863},{"date":"2025-10-24","current":-24.661157,"twenty":-21.072958,"median":-11.313477,"eighty":-4.962071,"marketCap":4086723598},{"date":"2025-10-31","current":-26.316108,"twenty":-21.100962,"median":-11.330122,"eighty":-4.964584,"marketCap":4360973893},{"date":"2025-11-07","current":-18.875595,"twenty":-21.108122,"median":-11.343438,"eighty":-4.966514,"marketCap":4172884368},{"date":"2025-11-14","current":-18.680224,"twenty":-21.103709,"median":-11.369961,"eighty":-4.970546,"marketCap":4129693081},{"date":"2025-11-21","current":-19.341879,"twenty":-21.100962,"median":-11.403361,"eighty":-4.973006,"marketCap":4275967218},{"date":"2025-11-28","current":-21.18323,"twenty":-21.101511,"median":-11.425388,"eighty":-4.974245,"marketCap":4683040205},{"date":"2025-12-05","current":-18.387864,"twenty":-21.101511,"median":-11.450359,"eighty":-4.976938,"marketCap":4065060323},{"date":"2025-12-12","current":-18.551996,"twenty":-21.091056,"median":-11.462665,"eighty":-4.977903,"marketCap":4101345380},{"date":"2025-12-19","current":-17.387688,"twenty":-21.085733,"median":-11.47284,"eighty":-4.980017,"marketCap":3843948255},{"date":"2025-12-26","current":-18.285282,"twenty":-21.079828,"median":-11.497644,"eighty":-4.980806,"marketCap":4042382162},{"date":"2026-01-02","current":-17.992923,"twenty":-21.075002,"median":-11.504096,"eighty":-4.981179,"marketCap":3977749404},{"date":"2026-01-09","current":-18.362219,"twenty":-21.07093,"median":-11.523207,"eighty":-4.981835,"marketCap":4059390783},{"date":"2026-01-16","current":-16.325962,"twenty":-21.067761,"median":-11.540459,"eighty":-4.982647,"marketCap":3609229291},{"date":"2026-01-23","current":-17.854437,"twenty":-21.06562,"median":-11.56138,"eighty":-4.984708,"marketCap":3947133887},{"date":"2026-01-30","current":-16.125926,"twenty":-21.05775,"median":-11.577513,"eighty":-4.992071,"marketCap":3565006877},{"date":"2026-02-06","current":-16.443931,"twenty":-21.05745,"median":-11.596174,"eighty":-4.995999,"marketCap":3635309176},{"date":"2026-02-13","current":-17.880082,"twenty":-21.024533,"median":-11.596174,"eighty":-4.995999,"marketCap":3952803427}],"updateTime":1771363674837},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609511820","title":"NewAmsterdam Pharma gewährt neuen Mitarbeitern Aktienoptionen im Rahmen des 2024 Inducement Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511820","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511820?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:01","pubTimestamp":1770411673,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV hat bekannt gegeben, dass der Vergütungsausschuss des Board of Directors die Gewhrung von Aktienoptionen für insgesamt 217.000 Stammaktien an vier neue nicht-geschftsführende Mitarbeiter genehmigt hat. Die Aktienoptionen wurden gem dem 2024 Inducement Plan mit einem Ausübungspreis von 31,57 US-Dollar pro Aktie vergeben und unterliegen einer vierjhrigen Vesting-Periode.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL71tKyk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","SG9999014039.USD","SG9999014013.SGD","BK4588","LU2210150020.SGD","LU2095319765.USD","BK4139","NAMS","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2608364813","title":"NewAmsterdam Pharma Executives to Join Guggenheim Emerging Outlook Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364813","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364813?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:00","pubTimestamp":1770210034,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company N.V. will participate in a virtual fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Wednesday, February 11, 2026, at 8:30 a.m. ET. Ian Somaiya, Chief Financial Officer, and Matthew Philippe, Executive Vice President, Head of Investor Relations, will represent the company at the event. A live webcast of the session will be available on the investor relations section of the NewAmsterdam Pharma website, with an archived replay accessible afterwards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8XYzWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00BKPKM429.USD","BK4112","NAMS","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2606756610","title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606756610","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606756610?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:39","pubTimestamp":1769553571,"startTime":"0","endTime":"0","summary":"Louise Frederika Kooij, Chief Accounting Officer of NewAmsterdam Pharma Company NV, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL5Vvr3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2605480584","title":"NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605480584","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605480584?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:25","pubTimestamp":1769120727,"startTime":"0","endTime":"0","summary":"Mayur Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma Company NV, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL9tfLtd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NewAmsterdam Pharma CFO Mayur Ian Somaiya Reports Disposal of Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2605265101","title":"RBC Raises Price Target on NewAmsterdam Pharma to $47 From $44, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605265101","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605265101?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:11","pubTimestamp":1768997518,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) has an average rating of buy and mean price target of $49.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2605050621","title":"NewAmsterdam Pharma Company Nv : RBC Raises Target Price to $47 From $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2605050621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605050621?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:08","pubTimestamp":1768993727,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM0IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2602356903","title":"Should NewAmsterdam’s Multi-Indication Obicetrapib Strategy Reshape How NAMS Investors View Pipeline Concentration?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602356903","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602356903?lang=en_us&edition=fundamental","pubTime":"2026-01-12 07:18","pubTimestamp":1768173537,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma recently outlined its late-stage plans for obicetrapib, including an expected EMA approval decision in the second half of 2026, first-patient dosing in the RUBENS Phase 3 metabolic syndrome trial, continued progress in the PREVAIL cardiovascular outcomes study, and preparations for an Alzheimer’s disease trial based on earlier biomarker data.\nThese updates give investors clearer visibility into NewAmsterdam’s pipeline evolution across cardiometabolic and neurological...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/should-newamsterdams-multi-indication-obicetrapib-strategy-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/should-newamsterdams-multi-indication-obicetrapib-strategy-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ISBC","BK4211","NAMS"],"gpt_icon":0},{"id":"2602376452","title":"NewAmsterdam Pharma highlights 2025 achievements, 2026 priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376452","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376452?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:10","pubTimestamp":1767964250,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) provided an update on the obicetrapib clinical development program and outlined its strategic priorities for 2026. Key 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-highlights-2025-achievements-2026-priorities-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-highlights-2025-achievements-2026-priorities-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2602750723","title":"NewAmsterdam Pharma Enrolls First Patients in RUBENS Phase 3 Trial for Obicetrapib Combo in Metabolic Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2602750723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602750723?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:01","pubTimestamp":1767963680,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL9K6ZKs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","NAMS","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","SG9999014039.USD","BK4139","SG9999014013.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2602376831","title":"NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376831","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376831?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:00","pubTimestamp":1767963629,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Outlines 2026 Strategic Priorities Including Anticipated EMA Approval Decision, Potential European Commercial Launch, and Ongoing Phase 3 Trials for Obicetrapib and Fixed-Dose Combination Therapies. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL3sHhbL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4585","BK4588","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","NAMS","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2602376866","title":"Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376866","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376866?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:00","pubTimestamp":1767963600,"startTime":"0","endTime":"0","summary":"-- Phase 3 PREVAIL CVOT overall event rate tracking in line with observed rate in BROADWAY --. -- Year-end cash, cash equivalents and marketable securities balance of approximately $729 million  --. NewAmsterdam is developing obicetrapib, an oral, low-dose, once-daily, and highly selective cholesteryl ester transfer protein  inhibitor, alone or as a fixed-dose combination with ezetimibe, as preferred LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of cardiovascular disease with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated.\"As we look to 2026, we remain committed to advancing our broader clinical development strategy, which includes three Phase 3 trials, PREVAIL, REMBRANDT, and RUBENS. In addition and based on the positive data from our Alzheimer's disease  biomarker analysis from the BROADWAY trial, we are planning to start our first dedicated Alzheimer's trial in 2026. This study could further dem","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2601233894","title":"NewAmsterdam Pharma Company Nv : Leerink Partners Raises Target Price to $55 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2601233894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601233894?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:18","pubTimestamp":1767701931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70J2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2601858692","title":"Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858692","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601858692?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:22","pubTimestamp":1767651758,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV ::*NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-JAN-202621:01:00.147 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nRSD3jpgjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2601832707","title":"NewAmsterdam Pharma Grants Stock Options to New Hire Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832707","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601832707?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:01","pubTimestamp":1767646867,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV has approved the grant of inducement share options for a new non-executive hire. The grant covers a total of 20,000 ordinary shares, with an exercise price of $35.20 per share, reflecting the closing market price on January 2, 2026. The options will vest over four years, with 25% vesting after the first year and the remaining shares vesting in equal monthly installments over the following three years, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL6pDsfY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","LU2095319765.USD","NDAQ","BK4139","SG9999014013.SGD","NAMS","SG9999014039.USD","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2595755830","title":"Chief Accounting Officer Louise Kooij Sells Common Shares of NewAmsterdam Pharma Company NV","url":"https://stock-news.laohu8.com/highlight/detail?id=2595755830","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595755830?lang=en_us&edition=fundamental","pubTime":"2025-12-30 06:14","pubTimestamp":1767046488,"startTime":"0","endTime":"0","summary":"Louise Frederika Kooij, Chief Accounting Officer of NewAmsterdam Pharma Company NV, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL15WXX3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Accounting Officer Louise Kooij Sells Common Shares of NewAmsterdam Pharma Company NV","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2594440658","title":"We're Hopeful That NewAmsterdam Pharma (NASDAQ:NAMS) Will Use Its Cash Wisely","url":"https://stock-news.laohu8.com/highlight/detail?id=2594440658","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594440658?lang=en_us&edition=fundamental","pubTime":"2025-12-24 22:52","pubTimestamp":1766587953,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/were-hopeful-that-newamsterdam-pharma-nasdaqnams-will-use-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/were-hopeful-that-newamsterdam-pharma-nasdaqnams-will-use-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","MNQmain","NVIW.SI","PSQ","TSYW.SI","USAW.SI",".IXIC","NQmain","QLD","SQQQ","TQQQ","QID","NAMS","USJW.SI"],"gpt_icon":1},{"id":"2591898235","title":"NewAmsterdam Pharma Company Nv : Stifel Raises Target Price to $50 From $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2591898235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591898235?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:09","pubTimestamp":1765890551,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2591687395","title":"National Presto, Garrett Motion, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2591687395","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591687395?lang=en_us&edition=fundamental","pubTime":"2025-12-13 07:50","pubTimestamp":1765583400,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 4 through Dec. 10, 2025. Source: VerityData. National Presto Industries  Albion River Management disclosed a new position in the diversified housewares and defense manufacturer of 362,350 shares. Albion River Management purchased 302,313 of those shares from Oct. 27 through Nov. 28 at per share prices ranging from $93.51 to $109.60.Following the latest purchases, Albion River Management owns a 5.1% stake in National Presto Industries' outstanding stock. Shares have gained roughly 6.7% in value since the beginning of this year.Following the latest sale, BCLS owns about 5% of NewAmsterdam Pharma's outstanding stock, representing overall economic exposure of 6.4% when including prefunded warran","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4187","BK4204","BK4211","IE0031619046.USD","NPK","BK4124","IE00B19Z4B17.USD","BK4141","IE00B7SZL793.SGD","IE00B66KJ199.SGD","ISBC","NAMS","UTI","GTX","BK4139","PI"],"gpt_icon":0},{"id":"2589981773","title":"NewAmsterdam Pharma Grants Stock Options to New Hires Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2589981773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589981773?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:01","pubTimestamp":1764968475,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company N.V. announced the approval of inducement share options for two new non-executive hires. The grants cover a total of 40,000 ordinary shares, with an exercise price of $39.61 per share, reflecting the closing market price on December 1, 2025. The options will vest over four years, with 25% vesting after one year and the remaining shares vesting in 36 equal monthly installments, contingent on continued employment. The grants were made under the company's 2024 Inducement Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on December 05, 2025, and is solely responsible for the information contained","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL14MZGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","NAMS","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","BK4139","BK4112"],"gpt_icon":0},{"id":"2586047316","title":"NewAmsterdam Pharma Executives to Join Major Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586047316","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586047316?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075629,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV will participate in several upcoming investor conferences in December 2025. The company will be represented at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL on December 2, the Citi's 2025 Global Healthcare Conference in Miami, FL on December 3, and the Piper Sandler 37th Annual Healthcare Conference in New York, NY on December 4. Live webcasts of the fireside chats will be available on the company's investor relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire  on November 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL8gnLHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVR","LU0320765646.SGD","LU1791807156.HKD","LU2125154935.USD","LU2462157665.USD","BK4504","NDAQ","LU1244550494.USD","BK4207","LU0072461881.USD","LU2456880835.USD","BK4585","LU2210149790.SGD","BK4112","LU0130517989.USD","BK4588","LU1244550221.USD","LU1668664300.SGD","LU0314104364.USD","IE00BSNM7G36.USD","LU0128525689.USD","LU0170899867.USD","LU1244550577.SGD","PIPR","IE00B3QW5Z07.USD","BK4566","LU0052756011.USD","IE00BKPKM429.USD","LU2125154778.USD","LU0130102774.USD","LU0098860793.USD","NAMS","IE00B64PRP62.GBP","LU2095319765.USD","BK4139","BK4559","LU0648001328.SGD","LU2236285917.USD","LU0477156953.USD","LU2360032135.SGD","LU2210150020.SGD","LU0310800965.SGD","LU2417539215.USD","IE00BGHQF748.EUR","BK4534","LU0106831901.USD","LU1201861249.SGD","LU1162221912.USD","LU1366192091.USD","LU0980610538.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}]}}